Diagnos Laboratorium Utama PT Tbk (DGNS) — Capital Reinvestment Ratio
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Capital Reinvestment Ratio of 1.74x as of June 2025, meaning it reinvests 2% of its operating cash flow (Rp1.52 Billion) in capital expenditures (Rp2.64 Billion). Check tangible net worth ratio of Diagnos Laboratorium Utama PT Tbk to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Diagnos Laboratorium Utama PT Tbk Capital Reinvestment Ratio (2018–2024)
This chart tracks Diagnos Laboratorium Utama PT Tbk's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see DGNS cash generation efficiency.
Annual Capital Reinvestment Ratio for Diagnos Laboratorium Utama PT Tbk (2018–2024)
Year-by-year Capital Reinvestment Ratio for Diagnos Laboratorium Utama PT Tbk from 2018 to 2024. See Diagnos Laboratorium Utama PT Tbk (DGNS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.59x | Rp27.30 Billion | Rp43.39 Billion | ▼ -45.3% |
| 2023 | 2.91x | Rp13.18 Billion | Rp38.32 Billion | ▲ +152.3% |
| 2021 | 1.15x | Rp58.87 Billion | Rp67.84 Billion | ▲ +415.4% |
| 2020 | 0.22x | Rp26.23 Billion | Rp5.86 Billion | ▼ -10.0% |
| 2019 | 0.25x | Rp11.20 Billion | Rp2.78 Billion | ▼ -45.2% |
| 2018 | 0.45x | Rp8.47 Billion | Rp3.84 Billion | — |